The incidence of adverse drug reactions in this surveillance. 8.5 Years (MAX) [clinicaltrials_resource:480fb32934a84d25c876b6712baf3677]
Patients administered Rifabutin.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
The incidence of adverse drug reactions in this surveillance. 8.5 Years (MAX) [clinicaltrials_resource:480fb32934a84d25c876b6712baf3677]
Patients administered Rifabutin.
Bio2RDF identifier
480fb32934a84d25c876b6712baf3677
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:480fb32934a84d25c876b6712baf3677
measure [clinicaltrials_vocabulary:measure]
The incidence of adverse drug reactions in this surveillance.
time frame [clinicaltrials_vocabulary:time-frame]
8.5 Years (MAX)
description
Patients administered Rifabutin.
identifier
clinicaltrials_resource:480fb32934a84d25c876b6712baf3677
title
The incidence of adverse drug reactions in this surveillance. 8.5 Years (MAX)
@en
type
label
The incidence of adverse drug ...... fb32934a84d25c876b6712baf3677]
@en